Nox4 NADPH oxidase mediates peroxynitrite-dependent uncoupling of endothelial nitric-oxide synthase and fibronectin expression in response to angiotensin II: Role of mitochondrial reactive oxygen species

Journal of Biological Chemistry

Volumn 288, Issue 40, 2013, Pages 28668-28686

  Lee, Doug Yoon ^a   Wauquier, Fabien ^a   Eid, Assaad A ^a   Roman, Linda J ^b   Ghosh Choudhury, Goutam ^a,c,d   Khazim, Khaled ^a   Block, Karen ^a,d   Gorin, Yves ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c Education and Clinical Center   (United States)

^d SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ENDOTHELIAL NITRIC-OXIDE SYNTHASE (ENOS); FIBRONECTIN EXPRESSION; MESANGIAL CELLS; NADPH OXIDASE; NITRIC-OXIDE SYNTHASE; REACTIVE OXYGEN SPECIES;

BIOCHEMISTRY; BIOLOGY;

OXYGEN;

3 NITROTYROSINE; ANGIOTENSIN II; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRONECTIN; MANGANESE SUPEROXIDE DISMUTASE; NITRIC OXIDE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; URIC ACID;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; GLOMERULUS; KIDNEY FIBROSIS; MESANGIUM CELL; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UPREGULATION;

ANGIOTENSIN II; EXTRACELLULAR MATRIX PROTEINS; KIDNEY; NITRIC-OXIDE SYNTHASE; NOX; OXIDATIVE STRESS;

ANGIOTENSIN II; ANIMALS; BIOLOGICAL AVAILABILITY; FIBRONECTINS; FIBROSIS; GENE SILENCING; INTRACELLULAR SPACE; MESANGIAL CELLS; MITOCHONDRIA; MODELS, BIOLOGICAL; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PEROXYNITROUS ACID; RATS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; SUPEROXIDES; UP-REGULATION;

EID: 84885118956     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.470971     Document Type: Article

References (78)

1. Chatziantoniou, C., and Dussaule, J. C. (2005) Insights into the mechanisms of renal fibrosis. Is it possible to achieve regression? Am. J. Physiol. Renal Physiol. 289, F227-F234
2. Gómez-Guerrero, C., Hernández-Vargas, P., López-Franco, O., Ortiz-Muñoz, G., and Egido, J. (2005) Mesangial cells and glomerular inflammation: from the pathogenesis to novel therapeutic approaches. Curr. Drug Targets Inflamm. Allergy 4, 341-351
3. Fogo, A. B. (1999) Mesangial matrix modulation and glomerulosclerosis. Exp. Nephrol. 7, 147-159
4. Abboud, H. E. (2012) Mesangial cell biology. Exp. Cell Res. 318, 979-985
5. Kim, S., and Iwao, H. (2000) Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol. Rev. 52, 11-34
6. Kagami S. (2012) Involvement of glomerular renin-angiotensin system (RAS) activation in the development and progression of glomerular injury. Clin. Exp. Nephrol. 16, 214-220
7. Lafayette, R. A., Mayer, G., Park, S. K., and Meyer, T. W. (1992) Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J. Clin. Invest. 90, 766-771
8. Ruiz-Ortega, M., Rupérez, M., Esteban, V., Rodríguez-Vita, J., Sánchez-López, E., Carvajal, G., and Egido, J. (2006) Angiotensin II. A key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol. Dial. Transplant. 21, 16-20
9. Rincon-Choles, H., Kasinath, B. S., Gorin, Y., and Abboud, H. E. (2002) Angiotensin II and growth factors in the pathogenesis of diabetic nephropathy. Kidney Int. Suppl. 82, S8-S11
10. Nistala, R., Whaley-Connell, A., and Sowers, J. R. (2008) Redox control of renal function and hypertension. Antioxid. Redox. Signal. 10, 2047-2089
11. Barnes, J. L., and Gorin, Y. (2011) Myofibroblast differentiation during fibrosis. Role of NAD(P)H oxidases. Kidney Int. 79, 944-956
12. Lassègue, B., San Martín, A., Griendling, K. K. (2012) Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ. Res. 110, 1364-1390
13. Gorin, Y., and Block, K. (2013) Nox4 and diabetic nephropathy: With a friend like this, who needs enemies? Free Radic. Biol. Med. 61C, 130-142
14. Gorin, Y., and Block, K. (2013) Nox as a target for diabetic complications. Clin. Sci. (Lond.) 125, 361-382
15. Bedard, K., and Krause, K. H. (2007) The NOX family of ROS-generating NADPH oxidases. Physiology and pathophysiology. Physiol. Rev. 87, 245-313
16. Garrido, A. M., and Griendling, K. K. (2009) NADPH oxidases and angiotensin II receptor signaling. Mol. Cell Endocrinol. 302, 148-158
17. Dikalov, S. I., and Nazarewicz, R. R. (2013) Angiotensin II-induced production of mitochondrial reactive oxygen species. Potential mechanisms and relevance for cardiovascular disease. Antioxid. Redox Signal. 19, 1085-1094
18. Dikalov, S. (2011) Cross talk between mitochondria andNADPHoxidases. Dikalov. Free Radic. Biol. Med. 51, 1289-1301
19. Dai, D. F., Rabinovitch, P. S., and Ungvari, Z. (2012) Mitochondria and cardiovascular aging. Circ. Res. 110, 1109-1124
20. Gorin, Y., Block, K., Hernandez, J., Bhandari, B., Wagner, B., Barnes, J. L., and Abboud, H. E. (2005) Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J. Biol. Chem. 280, 39616-39626
21. Block, K., Gorin, Y., and Abboud, H. E. (2009) Subcellular localization of Nox4 and regulation in diabetes. Proc. Natl. Acad. Sci. U.S.A. 106, 14385-14390
22. Kim, S. M., Kim, Y. G., Jeong, K. H., Lee, S. H., Lee, T. W., Ihm, C. G., and Moon, J. Y. (2012) Angiotensin II-induced mitochondrial Nox4 is a major endogenous source of oxidative stress in kidney tubular cells. PLoS One 7, e39739
23. Shah, A., Xia, L., Goldberg, H., Lee, K. W., Quaggin, S. E., and Fantus, I. G. (2013) Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species (ROS) generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells. J. Biol. Chem. 288, 6835-6848
24. Gorin, Y., Ricono, J. M., Kim, N. H., Bhandari, B., Choudhury, G. G., and Abboud, H. E. (2003) Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am. J. Physiol. Renal Physiol. 285, F219-F229
25. Block, K., Ricono, J. M., Lee, D. Y., Bhandari, B., Choudhury, G. G., Abboud, H. E., and Gorin, Y. (2006) Arachidonic acid-dependent activation of a p22phox-based NAD(P)H oxidase mediates angiotensin II-induced mesangial cell protein synthesis and fibronectin expression via Akt/PKB. Antioxid. Redox Signal. 8, 1497-1508
26. Block, K., Eid, A., Griendling, K. K., Lee, D. Y., Wittrant, Y., and Gorin, Y. (2008) Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II. Role in mesangial cell hypertrophy and fibronectin expression. J. Biol. Chem. 283, 24061-24076
27. Alp, N. J., and Channon, K. M. (2004) Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler. Thromb. Vasc. Biol. 24, 413-420
28. Förstermann, U., and Münzel, T. (2006) Endothelial nitric oxide synthase in vascular disease. From marvel to menace. Circulation 113, 1708-1714
29. Kietadisorn, R., Juni, R. P., and Moens, A. L. (2012) Tackling endothelial dysfunction by modulating NOS uncoupling. New insights into its pathogenesis and therapeutic possibilities. Am. J. Physiol. Endocrinol. Metab. 302, E481-E95
30. Thomas, S. R., Witting, P. K., and Drummond, G. R. (2008) Redox control of endothelial function and dysfunction. Molecular mechanisms and therapeutic opportunities. Antioxid. Redox Signal. 10, 1713-1765
31. Zhao, H. J., Wang, S., Cheng, H., Zhang, M. Z., Takahashi, T., Fogo, A. B., Breyer, M. D., and Harris, R. C. (2006) Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J. Am. Soc. Nephrol. 17, 2664-2669
32. Nakagawa, T., Sato, W., Glushakova, O., Heinig, M., Clarke, T., Campbell-Thompson, M., Yuzawa, Y., Atkinson, M. A., Johnson, R. J., and Croker, B. (2007) Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J. Am. Soc. Nephrol. 18, 539-550
33. Kanetsuna, Y., Takahashi, K., Nagata, M., Gannon, M. A., Breyer, M. D., Harris, R. C., and Takahashi, T. (2007) Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. Am. J. Pathol. 170, 1473-1484
34. Satoh, M., Fujimoto, S., Haruna, Y., Arakawa, S., Horike, H., Komai, N., Sasaki, T., Tsujioka, K., Makino, H., and Kashihara, N. (2005) NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am. J. Physiol. Renal Physiol. 288, F1144-F1152
35. Faria, A. M., Papadimitriou, A., Silva, K. C., Lopes de Faria, J. M., and Lopes de Faria, J. B. (2012) Uncoupling endothelial nitric oxide synthase is ameliorated by green tea in experimental diabetes by re-establishing tetrahydrobiopterin levels. Diabetes 61, 1838-1847
36. Zhang, W., Meng, H., Li, Z. H., Shu, Z., Ma, X., and Zhang, B. X. (2007) Regulation of STIM1, store-operated Ca2+ influx, and nitric oxide generation by retinoic acid in rat mesangial cells. Am. J. Physiol. Renal Physiol. 292, F1054-F1064
37. Satoh, M., Fujimoto, S., Arakawa, S., Yada, T., Namikoshi, T., Haruna, Y., Horike, H., Sasaki, T., and Kashihara, N. (2008) Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy. Nephrol. Dial. Transplant. 23, 3806-3813
38. Awad, A. S., Webb, R. L., Carey, R. M., and Siragy, H. M. (2004) Renal nitric oxide production is decreased in diabetic rats and improved by AT1 receptor blockade. J. Hypertens. 22, 1571-1577
39. New, D. D., Block, K., Bhandhari, B., Gorin, Y., and Abboud H. E. (2012) IGF-I increases the expression of fibronectin by Nox4-dependent Akt phosphorylation in renal tubular epithelial cells. Am. J. Physiol. Cell Physiol. 302, C122-C130
40. Eid, A. A., Ford, B. M., Block, K., Kasinath, B. S., and Gorin, Y., Ghosh-Choudhury, G., Barnes, J. L., and Abboud, H. E. (2010) AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes. J. Biol. Chem. 285, 37503-37512
41. Zou, M. H., Shi, C., and Cohen, R. A. (2002) Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J. Clin. Invest. 109, 817-826
42. Fernandes, D. C., Wosniak, J., Jr., Pescatore, L. A., Bertoline, M. A., Liberman, M., Laurindo, F. R., and Santos, C. X. (2007) Analysis of DHE-derived oxidation products by HPLC in the assessment of superoxide production and NADPH oxidase activity in vascular systems. Am. J. Physiol. Cell Physiol. 292, C413-C422
43. Kashyap, S. R., Roman, L. J., Lamont, J., Masters, B. S., Bajaj, M., Suraamornkul, S., Belfort, R., Berria, R., Kellogg, D. L., Jr., Liu, Y., and DeFronzo, R. A. (2005) Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects. J. Clin. Endocrinol. Metab. 90, 1100-1105
44. Roman, L. J., Sheta, E. A., Martasek, P., Gross, S. S., Liu, Q., and Masters, B. S. (1995) High-level expression of functional rat neuronal nitric oxide synthase in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 92, 8428-8432
45. Feliers, D., Chen, X., Akis, N., Choudhury, G. G., Madaio, M., and Kasinath, B. S. (2005) VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells. Kidney Int. 68, 1648-1659
46. Xia, Y. (2007) Superoxide generation from nitric oxide synthases. Antioxid. Redox Signal. 9, 1773-1778
47. Mount, P. F., and Power, D. A. (2006) Nitric oxide in the kidney. Functions and regulation of synthesis. Acta Physiol. (Oxf.) 187, 433-446
48. Wang, S., Shiva, S., Poczatek, M. H., Darley-Usmar, V., and Murphy-Ullrich, J. E. (2002) Nitric oxide and cGMP-dependent protein kinase regulation of glucose-mediated thrombospondin 1-dependent transforming growth factor- activation in mesangial cells. J. Biol. Chem. 277, 9880-9888
49. Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., and Harrison, D. G. (2003) Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest. 111, 1201-1209
50. Martyn, K. D., Frederick, L. M., von Loehneysen, K., Dinauer, M. C., and Knaus, U. G. (2006) Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal. 18, 69-82
51. Takac, I., Schröder, K., Zhang, L., Lardy, B., Anilkumar, N., Lambeth, J. D., Shah, A. M., Morel, F., and Brandes, R. P. (2011) The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J. Biol. Chem. 286, 13304-13313
52. Dikalov, S. I., Dikalova, A. E., Bikineyeva, A. T., Schmidt, H. H., Harrison, D. G., and Griendling, K. K. (2008) Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic. Biol. Med. 45, 1340-1351
53. Brandes, R. P., Takac, I., and Schröder, K. (2011) No superoxide-no stress? Nox4, the good NADPH oxidase! Arterioscler. Thromb. Vasc. Biol. 31, 1255-1257
54. Zhang, M., Perino, A., Ghigo, A., Hirsch, E., and Shah, A. M. (2013) NADPH oxidases in heart failure. Poachers or gamekeepers? Antioxid. Redox Signal. 18, 1024-1041
55. Schröder, K., Zhang, M., Benkhoff, S., Mieth, A., Pliquett, R., Kosowski, J., Kruse, C., Luedike, P., Michaelis, U. R., Weissmann, N., Dimmeler, S., Shah, A. M., and Brandes, R. P. (2012) Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ. Res. 110, 1217-1225
56. Craige, S. M., Chen, K., Pei, Y., Li, C., Huang, X., Chen, C., Shibata, R., Sato, K., Walsh, K., and Keaney, J. F., Jr. (2011) NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation. Circulation 124, 731-740
57. Dikalova, A. E., Góngora, M. C., Harrison, D. G., Lambeth, J. D., Dikalov, S., and Griendling, K. K. (2010) Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling. Am. J. Physiol. Heart Circ. Physiol. 299, H673-H679
58. Youn, J. Y., Gao, L., and Cai, H. (2012) The p47phox-and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes. Diabetologia 55, 2069-2079
59. Zhang, M., Song, P., Xu, J., and Zou, M. H. (2011) Activation of NAD(P)H oxidases by thromboxane A2 receptor uncouples endothelial nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol. 31, 125-132
60. Xu, J., Xie, Z., Reece, R., Pimental, D., and Zou, M. H. (2006) Uncoupling of endothelial nitric oxidase synthase by hypochlorous acid. Role of NAD(P)H oxidase-derived superoxide and peroxynitrite. Arterioscler. Thromb. Vasc. Biol. 26, 2688-2695
61. Cucoranu, I., Clempus, R., Dikalova, A., Phelan, P. J., Ariyan, S., Dikalov, S., and Sorescu, D. (2005) NAD(P)H oxidase 4 mediates transforming growth factor-1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ. Res. 97, 900-907
62. Lyle, A. N., Deshpande, N. N., Taniyama, Y., Seidel-Rogol, B., Pounkova, L., Du, P., Papaharalambus, C., Lassègue, B., and Griendling, K. K. (2009) Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ. Res. 105, 249-259
63. Spencer, N. Y., Yan, Z., Boudreau, R. L., Zhang, Y., Luo, M., Li, Q., Tian, X., Shah, A. M., Davisson, R. L., Davidson, B., Banfi, B., and Engelhardt J. F. (2011) Control of hepatic nuclear superoxide production by glucose 6-phosphate dehydrogenase and NADPH oxidase-4. J. Biol. Chem. 286, 8977-8987
64. Giacco, F., Brownlee, M. (2010) Oxidative stress and diabetic complications. Circ. Res. 107, 1058-1070
65. Dikalova, A. E., Bikineyeva, A. T., Budzyn, K., Nazarewicz, R. R., McCann, L., Lewis, W., Harrison, D. G., and Dikalov, S. I. (2010) Therapeutic targeting of mitochondrial superoxide in hypertension. Circ. Res. 107, 106-116
66. Doughan, A. K., Harrison, D. G., and Dikalov, S. I. (2008) Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction. Linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ. Res. 102, 488-496
67. Dai, D. F., Johnson, S. C., Villarin, J. J., Chin, M. T., Nieves-Cintrón, M., Chen, T., Marcinek, D. J., Dorn, G. W., 2nd, Kang, Y. J., Prolla, T. A., Santana, L. F., and Rabinovitch, P. S. (2011) Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ. Res. 108, 837-846
68. Radi, R., Cassina, A., Hodara, R., Quijano, C., and Castro, L. (2002) Peroxynitrite reactions and formation in mitochondria. Free Radic. Biol. Med. 33, 1451-1464
69. Gus'kova, R. A., Ivanov, I. I., Kol'tover, V. K., Akhobadze, V. V., and Rubin, A. B. (1984) Permeability of bilayer lipid membranes for superoxide (O2) radicals. Biochim. Biophys. Acta 778, 579-585
70. Martínez-Ruiz, A., Cadenas, S., and Lamas, S. (2011) Nitric oxide signaling. Classical, less classical, and nonclassical mechanisms. Free Radic. Biol. Med. 51, 17-29
71. Denicola, A., Souza, J. M., Radi, R., and Lissi E. (1996) Nitric oxide diffusion in membranes determined by fluorescence quenching. Arch. Biochem. Biophys. 328, 208-212
72. Gao, S., Chen, J., Brodsky, S. V., Huang, H., Adler, S., Lee, J. H., Dhadwal, N., Cohen-Gould, L., Gross, S. S., and Goligorsky, M. S. (2004) Docking of endothelial nitric oxide synthase (eNOS) to the mitochondrial outer membrane. A pentabasic amino acid sequence in the autoinhibitory domain of eNOS targets a proteinase K-cleavable peptide on the cytoplasmic face of mitochondria. J. Biol. Chem. 279, 15968-15974
73. Rafikov, R., Rafikova, O., Aggarwal, S., Gross, C., Sun, X., Desai, J., Fulton, D., and Black, S. M. (2013) Asymmetric dimethylarginine induces endothelial nitric oxide synthase mitochondrial redistribution through the nitration-mediated activation of Akt1. J. Biol. Chem. 288, 6212-6226
74. Plesková, M., Beck, K. F., Behrens, M. H., Huwiler, A., Fichtlscherer, B., Wingerter, O., Brandes, R. P., Mülsch, A., and Pfeilschifter, J. (2006) Nitric oxide down-regulates the expression of the catalyticNADPHoxidase subunit Nox1 in rat renal mesangial cells. FASEB J. 20, 139-141
75. Li, Y., and Wang, S. (2010) Glycated albumin activates NADPH oxidase in rat mesangial cells through up-regulation of p47phox. Biochem. Biophys. Res. Commun. 397, 5-11
76. Miyata, K., Rahman, M., Shokoji, T., Nagai, Y., Zhang, G. X., Sun, G. P., Kimura, S., Yukimura, T., Kiyomoto, H., Kohno, M., Abe, Y., and Nishiyama, A. (2005) Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells. J. Am. Soc. Nephrol. 16, 2906-2912
77. Radeke, H. H., Cross, A. R., Hancock, J. T., Jones, O. T., Nakamura, M., Kaever, V., and Resch, K. (1991) Functional expression ofNADPHoxidase components (α-and β-subunits of cytochrome b558 and 45-kDa flavoprotein) by intrinsic human glomerular mesangial cells. J. Biol. Chem. 266, 21025-21029
78. Lustgarten, M. S., Bhattacharya, A., Muller, F. L., Jang, Y. C., Shimizu, T., Shirasawa, T., Richardson, A., and Van Remmen, H. (2012) Complex I generated, mitochondrial matrix-directed superoxide is released from the mitochondria through voltage dependent anion channels. Biochem. Biophys. Res. Commun. 422, 515-521